Advanced signet-ring cell carcinoma of the stomach: Clinicopathological characteristics of patients and efficacy of the modified docetaxel, cisplatin, and fluorouracil regimen | Zendy

Yakup Bozkaya | Zendy; Gökmen Umut Erdem | Zendy; Nuriye Özdemir | Zendy; Cemil Hocazade | Zendy; Ozan Yazıcı | Zendy; Nebi Serkan Demirci | Zendy; Nurullah Zengin | Zendy

Open Access

Advanced signet-ring cell carcinoma of the stomach: Clinicopathological characteristics of patients and efficacy of the modified docetaxel, cisplatin, and fluorouracil regimen

Author(s) -

Yakup Bozkaya,

Gökmen Umut Erdem,

Nuriye Özdemir,

Cemil Hocazade,

Ozan Yazıcı,

Nebi Serkan Demirci,

Nurullah Zengin

Publication year - 2018

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.184514

Subject(s) - docetaxel , medicine , regimen , mucositis , neutropenia , gastroenterology , fluorouracil , chemotherapy , signet ring cell carcinoma , nausea , febrile neutropenia , chemotherapy regimen , cisplatin , surgery , progressive disease , oncology , cancer , adenocarcinoma

The aim of this retrospective study was to investigate the clinicopathological characteristics of patients with signet-ring cell carcinoma (SRCC) of the stomach, and the efficacy of the modified docetaxel, cisplatin, and fluorouracil (mDCF) chemotherapy regimen.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research